INS and diabetes mellitus: Al-Salami et al. [22] claimed that diabetic rats, which were treated with probiotics, increased gliclazide bioavailability and lowered BG levels by insulin-independent mechanisms, suggesting that the administration of probiotics may be beneficial as adjunct therapy in the treatment of diabetes.